
MIRA PHARMACEUTICALS, INC.
MIRA PHARMACEUTICALS, INC. (MIRA)
WebsitePrice
Market cap
Next catalystPhase 2a CIPN initiation targeted for Q2 2027, subject to FDA clearance, site readiness, and other regulatory and operational factorsKetamir-2 — planned Phase 2a CIPN study · Trial initiationSEC filing ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved